Healthtech Investors & VC Firms in Europe
191 firms in this list, with a median first check of $635K. 20 of them lead rounds. Generated from verified public data and updated continuously.
Shaping Impact Group
BrusselsSeed–Series B$270K – $1.6M
7 people
SpeedUp Venture Capital Group
PoznanSeed–Series A$54K – $1.6M
7 people
UNIQA Ventures GmbH
ViennaSeed–Series B$1.1M – $5.4M
7 people
Banana Capital
SeattlePre-Seed–Seed$1 – $250K
Rapid Scale
Las VegasSeries A–Growth
Crede CapitalGroup
Los Angeles$5M – $50M
Ajax Health
Menlo ParkSeed–Late Stage
9 people
Heal Capital
BerlinPre-Seed–Late Stage$1.1M – $5.4M
6 people
Inkef
AmsterdamSeed–Series A
9 people
Invivo Capital Partners
BarcelonaPre-Seed–Series A$2.2M – $4.3M
6 people
Nina Capital
BarcelonaPre-Seed–Series A$216K – $1.6M
6 people
Partners Investment Co. Ltd.
SeoulSeries A–Late Stage
9 people
Crista Galli Ventures
LondonSeed–Series A
2 people
Backed
LondonSeed$540K – $2.7M
5 people
Cross-Border Impact Ventures
TorontoSeries A–Series B$2M – $10M
5 people
Debiopharm Innovation Fund
LausanneSeries A–Late Stage$3M – $5M
5 people
Delta Partners
DublinSeed–Series A$108K – $3.2M
5 people
Empower Capital
SofiaSeries A–Series B$270K – $3.2M
5 people
GR Capital
LondonGrowth$3.2M – $10.8M
5 people
HEARTFELT_
BerlinPre-Seed–Series A
8 people
Innovation Nest
KrakowSeed–Series A$108K – $1.1M
5 people
Kennet Partners
LondonGrowth–Late Stage$8.6M – $32.4M
5 people
Laerdal Million Lives Fund
San FranciscoSeries A–Series B$1M – $5M
5 people
MSD Global Health Innovation Fund
RahwaySeries A–Late Stage$1M – $30M
5 people
Related lists
Crypto & Web3 Investors & VC Firms (3510)Investors & VC Firms in United States (2654)SaaS Investors & VC Firms (1994)Enterprise Software Investors & VC Firms (1791)Fintech Investors & VC Firms (1455)Healthtech Investors & VC Firms (1333)Consumer Investors & VC Firms (1247)Biotech Investors & VC Firms (1141)Data & Infrastructure Investors & VC Firms (1088)SaaS Investors & VC Firms in United States (1064)
Data sourced from public filings and firms' own websites — see our methodology.